NCT01197248

Brief Summary

Up to 50% of patients undergoing pelvic floor repair experience short-term postoperative voiding dysfunction, increasing the length of hospitalization, cost and anxiety among patients. The mechanism behind this problem is the sutures placed in the pubocervical fascia during the cystocele repair. The cited benefit of bladder plication is greater cure of cystocele. The existence of pubocervical fascia and the need for placement of plicating sutures over the bladder have been questioned. The objective of this study is to determine if avoiding cystocele plication in women undergoing surgery for cystocele decreases the need of catheterization beyond post operative day #2. We will conduct a RCT of patients undergoing transvaginal repair of midline cystocele at the Mount Sinai Hospital. Patients will be randomized to receiving plicating sutures versus no plication. This procedure may be conducted with or without concomitant correction of other sites of prolapse. However, they will not have any procedures for correction of stress incontinence. This study will be powered to detect a reduction in voiding dysfunction from 50% to 25% of patients. Using a χ2 distribution, and an alpha error of 0.05, the required sample size is 58 patients per group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Feb 2009

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

August 17, 2010

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 9, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
Last Updated

December 20, 2016

Status Verified

December 1, 2016

Enrollment Period

1.6 years

First QC Date

August 17, 2010

Last Update Submit

December 17, 2016

Conditions

Keywords

cystocelevoidingdysfunction

Outcome Measures

Primary Outcomes (1)

  • Post operative voiding dysfunction

    The primary outcome variable will be the requirement for bladder catheterization beyond postoperative day 2

    24 hours post intervention

Secondary Outcomes (1)

  • Ureteric Obstruction

    Intraoperative

Study Arms (2)

Cystocele Plication

ACTIVE COMPARATOR

Placement of sutures over the pubocervical fascia during cystocele repair.

Procedure: Cystocele plication

No Plication

EXPERIMENTAL

Avoid sutures over pubocervical fascia during cystocele repair

Procedure: No Plication

Interventions

placement of sutures over the pubocervical fascia during the cystocele repair

Also known as: Cystocele reduction
Cystocele Plication
No PlicationPROCEDURE

Avoid sutures over pubocervical fascia during cystocele plication

Also known as: No plicating sutures
No Plication

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 18 and 75 years, who will undergo surgery at the Mount Sinai Hospital that includes cystocele repair, will be eligible.

You may not qualify if:

  • Patients will be excluded if the surgeon places anterior vaginal mesh or a mid-urethral sling, and/or if they had prior surgery for anterior vaginal wall prolapse and/or stress urinary incontinence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cystocele

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Danny Lovatsis, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

August 17, 2010

First Posted

September 9, 2010

Study Start

February 1, 2009

Primary Completion

September 1, 2010

Study Completion

November 1, 2010

Last Updated

December 20, 2016

Record last verified: 2016-12